| Patient‐reported reasons for discontinuing overactive bladder medication JS Benner, MB Nichol, ES Rovner, Z Jumadilova, J Alvir, M Hussein, ... BJU international 105 (9), 1276-1282, 2010 | 430 | 2010 |
| Estimated prevalence of undiagnosed atrial fibrillation in the United States MP Turakhia, J Shafrin, K Bognar, J Trocio, Y Abdulsattar, D Wiederkehr, ... PloS one 13 (4), e0195088, 2018 | 168 | 2018 |
| DermaVir: a novel topical vaccine for HIV/AIDS J Lisziewicz, J Trocio, L Whitman, G Varga, J Xu, N Bakare, P Erbacher, ... Journal of investigative dermatology 124 (1), 160-169, 2005 | 131 | 2005 |
| Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records M Sussman, J Trocio, C Best, S Mirkin, AG Bushmakin, R Yood, ... BMC Women's Health 15, 1-5, 2015 | 101 | 2015 |
| Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States MP Turakhia, J Shafrin, K Bognar, DP Goldman, PM Mendys, ... The American journal of cardiology 116 (5), 733-739, 2015 | 101 | 2015 |
| Control of viral rebound through therapeutic immunization with DermaVir J Lisziewicz, J Trocio, J Xu, L Whitman, A Ryder, N Bakare, MG Lewis, ... Aids 19 (1), 35-43, 2005 | 96 | 2005 |
| Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients S Deitelzweig, X Luo, K Gupta, J Trocio, J Mardekian, T Curtice, ... Current medical research and opinion 33 (10), 1745-1754, 2017 | 86 | 2017 |
| Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared … A Amin, A Keshishian, J Trocio, O Dina, H Le, L Rosenblatt, X Liu, ... Current medical research and opinion 33 (9), 1595-1604, 2017 | 75 | 2017 |
| Challenges for managing overactive bladder and guidance for patient support VF Schabert, T Bavendam, EL Goldberg, JN Trocio, L Brubaker Am J Manag Care 15 (4 Suppl), S118-22, 2009 | 64 | 2009 |
| IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine SA Calarota, A Dai, JN Trocio, DB Weiner, F Lori, J Lisziewicz Vaccine 26 (40), 5188-5195, 2008 | 56 | 2008 |
| DermaVir, a novel HIV immunisation technology F Lori, J Trocio, N Bakare, LM Kelly, J Lisziewicz Vaccine 23 (17-18), 2030-2034, 2005 | 53 | 2005 |
| Predictors of discontinuing overactive bladder medications L Brubaker, K Fanning, EL Goldberg, JS Benner, JN Trocio, T Bavendam, ... BJU international 105 (9), 1283-1290, 2010 | 51 | 2010 |
| An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants S Deitelzweig, A Bruno, J Trocio, N Tate, K Gupta, J Lin, M Lingohr-Smith Current medical research and opinion 32 (3), 573-582, 2016 | 50 | 2016 |
| Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in nonvalvular atrial fibrillation patients in the US Department of Defense Population K Gupta, J Trocio, A Keshishian, Q Zhang, O Dina, J Mardekian, ... Journal of managed care & specialty pharmacy 24 (11), 1116-1127, 2018 | 42 | 2018 |
| HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3 AD Cristillo, J Lisziewicz, L He, F Lori, L Galmin, JN Trocio, T Unangst, ... Virology 366 (1), 197-211, 2007 | 42 | 2007 |
| Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism … A Amin, A Bruno, J Trocio, J Lin, M Lingohr-Smith Journal of Medical Economics 18 (6), 399-409, 2015 | 40 | 2015 |
| Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model S Arlandis-Guzman, C Errando-Smet, J Trocio, D Arumi, J Rejas BMC urology 11, 1-11, 2011 | 38 | 2011 |
| Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting J Lin, J Trocio, K Gupta, J Mardekian, M Lingohr-Smith, B Menges, M You, ... Journal of medical economics 20 (9), 952-961, 2017 | 33 | 2017 |
| Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire L Brubaker, V Khullar, E Piault, CJ Evans, T Bavendam, J Beach, Y Yeh, ... International urogynecology journal 22, 937-946, 2011 | 33 | 2011 |
| Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English E Piault, S Doshi, BA Brandt, Ç Angün, CJ Evans, A Bergqvist, J Trocio Health and quality of life outcomes 10, 1-9, 2012 | 32 | 2012 |
Jason ShafrinFTI Consulting & University of Southern CaliforniaVerified email at fticonsulting.com
